Recently, we have reported that buspirone as a partial agonist of 5-HT1A receptors, improves catalepsy induced by 6-hydroxydopamine (10) and haloperidol (11) as animal models of Parkinson’s disease. Here, HTR1A is linked to Parkinson disease.